Latin America Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, anti-cancer drugs, respiratory products, and others) –Industry analysis, size, share, growth, trends, and forecasts (2016-2021)

Latin America Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, anti-cancer drugs, respiratory products, and others) –Industry analysis, size, share, growth, trends, and forecasts (2016-2021)

ID: 2187 | Pages: 180 | May 2017 | Region: Latin America


Latin America Generic drugs market was worth USD 43.04 billion in 2016 and is expected to reach USD 73.72 billion by 2021 with a CAGR of 11.0 %. This market will increase tremendously during forecast period.

Generic drugs are also known as abbreviated drugs. Generic Drugs are Equivalent or Bioequivalent to brand name drug in terms of Side effects, Risks, Dosage, Intended use, and Strength. Although they are equivalent to their brand name counterparts, they are sold at a substantially lower price. To sell a generic drug manufacturing company must submit an Abbreviated New Drug Application for approval after the patent of brand name counterpart expires.

The cost-effectiveness of abbreviated drugs has given it a competitive lead over branded drugs in the market. Key driving factor for generic drugs is patent expiry for branded drugs. Patent for Branded drugs with sales of up to USD 135 billion was expired in 2015. Nearly USD 150 billion worth of patents for branded drugs will expire by 2020 which will give generic drugs a huge advantage.  One more trend which influences market growth is outsourcing. Presence of some key players in this market and developing economies are some driving factors in this region. Vendors are using outsourcing as a strategy to reduce their capital which will be an advantage to generic drugs. Only restraint for this market is rigid rules setup by FDA for approval of these drugs and the threat of counterfeit drugs.

Generic drugs market is segmented into Biosimilars, Simple generic and Super generic. Based on therapeutic drugs, they are further segmented into Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, anti-cancer drugs, respiratory products, and others. Super generics are sold at higher price than their pure generic counterpart. Super generics account for 18% of total spending on generic drugs. But biosimilars are comparatively cost effective even among generic drugs. Biosimilar drugs is expected to have significant growth during the forecast period. Based on Geography, this region is further divided in to Brazil, Argentina, Mexico and rest of Latin America. Brazil has highest CAGR in this region

Key players in this market are Ranbaxy Laboratories, Ltd, Actavis, Mylan, Inc., Industries, Ltd., Dr. Reddy’s Laboratories, Par Pharmaceutical, Inc., Sandoz International GmbH, Hospira, Inc., Apotex, Inc., Watson Pharmaceuticals, Ltd., Teva Pharmaceutical and others.

1.Introduction                                                                  

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Type                                                              

                                5.1.1 Introduction                                           

                                5.1.2 Biosimilars                                               

                                5.1.3 simple generics                                     

                                5.1.4 Super generics                                      

                                5.1.5  Y-o-Y Growth Analysis, By Product                                              

                                5.1.6  Market Attractiveness Analysis, By Product                                            

                                5.1.7  Market Share Analysis, By Product                                              

                5.2 Therapeutic drugs                                                   

                                5.2.1 Introduction                                           

                                5.2.2 Cardiovascular Products                                    

                                5.2.3 Anti-infective Drugs                                            

                                5.2.4 Anti Arthritis Drugs                                              

                                5.2.5 Central Nervous System Drugs                                       

                                5.2.6 Anti Cancer Drugs                                

                                5.2.7 Respiratory System Drugs                                

                                5.2.8 Others                                      

                                5.2.9 Y-o-Y Growth Analysis, By Therapeutic Drugs                                          

                                5.2.10 Market Attractiveness Analysis, By Therapeutic Drugs                                      

                                5.2.11 Market Share Analysis, By Therapeutic Drugs                                        

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Type                 

                                                6.1.3.3 By Therapeutic Drugs                      

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Type                 

                                                6.1.4.3 By Therapeutic Drugs                      

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By type                 

                                                6.1.5.3 By Therapeutic Drugs                      

                6.2 Brazil                                                             

                6.3 Mexico                                                         

                6.4 Rest of Latin America                                                             

7.Strategic Analysis                                                                        

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                                                                         

                8.1 Ranbaxy Laboratories                                                            

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Actavis                                                          

                8.3 Mylan, Inc. Industries, Ltd.                                                  

                8.4 Dr. Reddy’s Laboratories                                                      

                8.5 Par Pharmaceutical, Inc.                                                        

                8.6 Sandoz International GmbH                                                

                8.7 Celgene Corporation                                                              

                8.8 Apotex, Inc.                                                               

                8.9 Watson Pharmaceuticals, Ltd.                                                            

                8.10 Teva Pharmaceutical and others.                                                    

9.Competitive Landscape                                                                            

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10.Market Outlook and Investment Opportunities                                                                          

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Latin America Generic Drugs Market By Type, From 2016-2021 ( USD Billion )
  2. Latin America Biosimilars Market By Region, From 2016-2021 ( USD Billion )
  3. Latin America Simple Generics Market By Region, From 2016-2021 ( USD Billion )
  4. Latin America Super Generics Market By Region, From 2016-2021 ( USD Billion )
  5. Latin America Generic Drugs Market By Therapeutic Drugs, From 2016-2021 ( USD Billion )
  6. Latin America Cardiovascular Drugs Market By Region, From 2016-2021 ( USD Billion )
  7. Latin America Anti-Infective Drugs Market By Region, From 2016-2021 ( USD Billion )
  8. Latin America Anti-Arthritic Drugs Market By Region, From 2016-2021 ( USD Billion )
  9. Latin America Central Nervous system Drugs Market By Region, From 2016-2021 ( USD Billion )
  10. Latin America Anti-Cancer Drugs Market By Region, From 2016-2021 ( USD Billion )
  11. Latin America Respiratory Products Market By Region, From 2016-2021 ( USD Billion )
  12. Latin America Others Market By Region, From 2016-2021 ( USD Billion )
  13. Brazil Generic Drugs Market By Type, From 2016-2021 ( USD Billion )
  14. Brazil Generic Drugs Market By Therapeutic Drugs, From 2016-2021 ( USD Billion )
  15. Argentina Generic Drugs Market By Type, From 2016-2021 ( USD Billion )
  16. Argentina Generic Drugs Market By Therapeutic Drugs, From 2016-2021 ( USD Billion )
  17. Mexico Generic Drugs Market By Type, From 2016-2021 ( USD Billion )
  18. Mexico Generic Drugs Market By Therapeutic Drugs, From 2016-2021 ( USD Billion )
  19. Rest of Latin America Generic Drugs Market By Type, From 2016-2021 ( USD Billion )
  20. Rest of Latin America Generic Drugs Market By Therapeutic Drugs, From 2016-2021 ( USD Billion )
Middle East And Africa Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Applic...
Latin America Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Re...
Asia Pacific Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Res...
Europe Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Research ...
North America Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Re...
Radioimmunoassay Market By Type (Reagents And Kits Market, Analysers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Research And Cli...
Middle East And Africa Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, G...
Latin America Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric El...
Asia Pacific Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Ele...
Europe Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electrica...
North America Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric El...
Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electrical Stimu...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.